Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
How Patients With Multiple Sclerosis Perceive Cognitive Slowing.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Does the immune system act as a self-organized system in multiple sclerosis?
Therapeutic decision making in a new drug era in multiple sclerosis.
Olfactory System and Demyelination.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Primary CNS lymphoma masquerading as tumefactive demyelination.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis.
Statins and Neuroprotection: Basic Pharmacology Needed.
Optic neuritis revealing Kikuchi-Fujimoto disease.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
Associations between Proprioceptive Neural Pathway Structural Connectivity and Balance in People with Multiple Sclerosis.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease.
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
Pages
« first
‹ previous
…
366
367
368
369
370
371
372
373
374
…
next ›
last »